Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical.
Matrix Capital Management
Wharton Asset Management Company Limited
Cambridge, Massachusetts, United States
Early Stage Venture
$1M to $10M
Register and Claim Ownership